Figure 5From: RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression MiR-93-5P inhibited tumor growth in vivo. Tumor xenograft volume in nude mice treated with miR-93-5P was smaller than that in mock nude mice (A). Tumor xenograft growth in miR-93-5P–treated nude mice was slower than that in the control group from day 4 and week 2 onwards (B), and the DV increased in the latter period (C).Back to article page